Tempus Schedules Q1 2026 Results and Business Update, Highlighting AI Progress in Precision Medicine
Market Chameleon (Tue, 21-Apr 4:46 AM ET)
Tempus to Report First Quarter 2026 Financial Results on May 5
Business Wire (Tue, 21-Apr 8:30 AM ET)
Benzinga (Sun, 19-Apr 10:01 AM ET)
Tempus, Adobe, Helus, Constellation, Stryker Trending With Analysts
TipRanks (Sat, 18-Apr 5:01 AM ET)
Catalyst Watch: Tesla talks AI5 chips, Intel reports, and the Warner Bros. deal goes to a vote
Seeking Alpha News (Fri, 17-Apr 3:00 PM ET)
Market Chameleon (Wed, 15-Apr 7:46 AM ET)
Business Wire (Wed, 15-Apr 8:30 AM ET)
Business Wire (Tue, 14-Apr 8:30 AM ET)
Tempus Launches Automated "Active Follow-Up" Service to Support Guideline-Concordant Care
Business Wire (Mon, 13-Apr 8:30 AM ET)
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE
Business Wire (Thu, 9-Apr 8:30 AM ET)
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Tempus Ai - Class A trades on the NASDAQ stock market under the symbol TEM.
As of April 22, 2026, TEM stock price climbed to $56.04 with 1,501,227 million shares trading.
TEM has a beta of 2.75, meaning it tends to be more sensitive to market movements. TEM has a correlation of 0.26 to the broad based SPY ETF.
TEM has a market cap of $10.02 billion. This is considered a Large Cap stock.
Last quarter Tempus Ai - Class A reported $367 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.10.
The top ETF exchange traded funds that TEM belongs to (by Net Assets): ARKK, VTI, VB, ARKG, BAI.
TEM has underperformed the market in the last year with a return of +36.7%, while the SPY ETF gained +39.6%. In the last 3 month period, TEM fell short of the market, returning -14.2%, while SPY returned +3.8%. However, in the most recent 2 weeks TEM has outperformed the stock market by returning +19.7%, while SPY returned +7.7%.
TEM support price is $52.21 and resistance is $58.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TEM shares will trade within this expected range on the day.